These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 2080339)

  • 21. The use of genetically altered astrocytes to provide nerve growth factor to adrenal chromaffin cells grafted into the striatum.
    Cunningham LA; Hansen JT; Short MP; Bohn MC
    Brain Res; 1991 Oct; 561(2):192-202. PubMed ID: 1686984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic implants of chromaffin tissue into the dopamine-denervated striatum. Effects of NGF on graft survival, fiber growth and rotational behavior.
    Strömberg I; Herrera-Marschitz M; Ungerstedt U; Ebendal T; Olson L
    Exp Brain Res; 1985; 60(2):335-49. PubMed ID: 4054276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral transplantation for Parkinson's disease: current progress and future prospects.
    Ahlskog JE
    Mayo Clin Proc; 1993 Jun; 68(6):578-91. PubMed ID: 8497136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transplantation of adrenal tissue into the central nervous system.
    Fine A
    Brain Res Brain Res Rev; 1990; 15(2):121-33. PubMed ID: 2282448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracerebral co-grafting of Schwann's cells and fetal adrenal medulla in the treatment of Parkinson's disease.
    Zhang WC; Ding YJ; Cao JK; Du JX; Zhang GF; Liu YJ
    Chin Med J (Engl); 1994 Aug; 107(8):583-8. PubMed ID: 7805441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patients.
    Levivier M; Dethy S; Rodesch F; Peschanski M; Vandesteene A; David P; Wikler D; Goldman S; Claes T; Biver F; Liesnard C; Goldman M; Hildebrand J; Brotchi J
    Stereotact Funct Neurosurg; 1997; 69(1-4 Pt 2):99-111. PubMed ID: 9711741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neural transplantation for Parkinson's disease.
    Date I; Ohmoto T
    Cell Mol Neurobiol; 1999 Feb; 19(1):67-78. PubMed ID: 10079966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromaffin cell survival and host dopaminergic fiber recovery in a patient with Parkinson's disease treated by cografts of adrenal medulla and pretransected peripheral nerve. Case report.
    Date I; Imaoka T; Miyoshi Y; Ono T; Asari S; Ohmoto T
    J Neurosurg; 1996 Apr; 84(4):685-9. PubMed ID: 8613865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NGF-like trophic support from peripheral nerve for grafted rhesus adrenal chromaffin cells.
    Kordower JH; Fiandaca MS; Notter MF; Hansen JT; Gash DM
    J Neurosurg; 1990 Sep; 73(3):418-28. PubMed ID: 2384781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery.
    Kordower JH; Goetz CG; Freeman TB; Olanow CW
    Exp Neurol; 1997 Mar; 144(1):41-6. PubMed ID: 9126150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain grafts and Parkinson's disease.
    Freed WJ; Poltorak M; Takashima H; LaMarca ME; Ginns EI
    J Cell Biochem; 1991 Mar; 45(3):261-7. PubMed ID: 2066376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human fetal tissues grafted to rodent hosts: structural and functional observations of brain, adrenal and heart tissues in oculo.
    Olson L; Strömberg I; Bygdeman M; Granholm AC; Hoffer B; Freedman R; Seiger A
    Exp Brain Res; 1987; 67(1):163-78. PubMed ID: 3305059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cellular transplants for Parkinson's disease].
    Guridi J; Herrero MT; Luquin MR; Obeso JA
    Neurologia; 1991 May; 6(5):175-83. PubMed ID: 1873045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fetal brain grafts and Parkinson's disease.
    Science; 1990 Dec; 250(4986):1434-5. PubMed ID: 2255915
    [No Abstract]   [Full Text] [Related]  

  • 35. Cells of the sympathoadrenal lineage: biological properties as donor tissue for cell-replacement therapies for Parkinson's disease.
    Fernandez-Espejo E; Armengol JA; Flores JA; Galan-Rodriguez B; Ramiro S
    Brain Res Brain Res Rev; 2005 Sep; 49(2):343-54. PubMed ID: 16111561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving the survival of grafted dopaminergic neurons: a review over current approaches.
    Brundin P; Karlsson J; Emgård M; Schierle GS; Hansson O; Petersén A; Castilho RF
    Cell Transplant; 2000; 9(2):179-95. PubMed ID: 10811392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical application of cell grafting techniques in patients with Parkinson's disease.
    Quinn NP
    Prog Brain Res; 1990; 82():619-25. PubMed ID: 2290963
    [No Abstract]   [Full Text] [Related]  

  • 38. Autologous adrenal medullary, fetal mesencephalic, and fetal adrenal brain transplantation in Parkinson's disease: a long-term postoperative follow-up.
    Madrazo I; Franco-Bourland R; Aguilera M; Ostrosky-Solis F; Madrazo M; Cuevas C; Catrejon H; Guizar-Zahagun G; Magallon E
    J Neural Transplant Plast; 1991; 2(3-4):157-64. PubMed ID: 1782251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease.
    Kordower JH; Freeman TB; Chen EY; Mufson EJ; Sanberg PR; Hauser RA; Snow B; Olanow CW
    Mov Disord; 1998 May; 13(3):383-93. PubMed ID: 9613726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Surgical treatment of Parkinson's disease].
    Komai N
    Nihon Rinsho; 1993 Nov; 51(11):2940-6. PubMed ID: 8277575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.